Company Analysis

Haoxi Health Technology Limited (HAO)

Nasdaq: HAO · Services-Advertising Agencies · Beijing · filing with the SEC since 2023
Grade4.9
◀ Past 5.8● Present 4.3▶ Future 4.7
2 est.
The companyfiscal 2026, as filed
Revenue$54.8M+67.1%
Net income-$9.5M-346.0%
Earnings per share$-386.40-111.4%
Operating cash flow-$2.6M+23.5%
Cash$10.9M+26.9%
Debtn/a
Shareholders’ equity$17.9M+2.8%
Shares, diluted24,680+2536.8%
Return on equity-53.4%
The recordfrom its filings
Filings in 202624
Newest filingNov 12 · F-3
Annual reportSep 30, 2026
Quarterly reportn/a
Next report due20-F by Oct 28
Insider sales, 12 months$0.00
Insider buys, 12 months$800,000
Patents grantedn/a
Filer categoryNon-accelerated filer<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
2223242526
As filed, in USD. Nothing here is a forecast.

News

Jul 13, 2026 · SEC EDGAR · Form 424B5
Shelf offering
Open the filing on sec.gov
May 20, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton HAO · research, not advice